We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Heart-Type Fatty Acid Binding Protein Assay Launched

By LabMedica International staff writers
Posted on 27 Jun 2011
Print article
Heart-type fatty acid binding protein (H-FABP) is a sensitive and specific biomarker of myocardial ischemia that can used for the diagnosis of acute coronary syndrome (ACS), via a new CE-marked laboratory assay. The H-FABP assay is ready to be implemented into routine clinical practice, in combination with troponin.

H-FABP is a 15-kDa cytoplasmic protein that is involved in the intracellular uptake and buffering of free fatty acids in the myocardium. It is released within 30 minutes of an ischemic episode and is 20 times more cardiac specific than myoglobin.

Randox (Crumlin, United Kingdom) announced the worldwide launch of the quantitative, automated laboratory assay for H-FABP. Studies have shown that H-FABP has highly significant and additive diagnostic value, especially during the early hours following ACS symptom onset. Such results are particularly valuable, as this has traditionally been a "troponin-blind" period for hospital emergency departments and numerous patients are conservatively admitted for further observation, in many cases, unnecessarily.

The results of one recently completed trial from the University of Manchester (United Kingdom) were presented at the IFCC EuroMedLab conference in Berlin on May 17, 2011. The results of the trial suggest that utilizing a combination hsTnT, H-FABP, and ECG on admission, could act as a highly accurate test to rule out acute myocardial infarction (AMI).

CEO of Randox Laboratories, Dr. Peter Fitzgerald, believes that the release of this new laboratory-based assay represents a new era in the clinical use of acute cardiac biomarkers. He explained, "The new Randox H-FABP assay is a simple and rapid test that can be performed on a wide range of clinical chemistry analyzers, without the need for specialist software, training, or equipment. We believe it represents a wonderful opportunity to improve the management of patients with suspected ACS and enable a more effective utilization of healthcare resources."

Related Links:
Randox
University of Manchester


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
PSA Test
Human Semen Rapid Test

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.